Our findings indicated that in the COAD cohort, the Ma2-APOE cluster was associated with a poor prognosis in colon cancer, whereas the cDC1, CD8+Trm, and CD4+Tn clusters were associated with a good prognosis. Here, CD4 is linked to malignant colon neoplasm.